STOP DIABETES - Knowledge-based Solutions

Launched by UNIVERSITY OF EASTERN FINLAND · May 15, 2017

Keywords

ClinConnect Summary

The STOP DIABETES - Knowledge-based Solutions trial is designed to help people at risk of developing type 2 diabetes by encouraging healthier lifestyle choices. This study will involve around 10,000 people aged 18 to 70 who live in specific areas of Finland and have a higher likelihood of diabetes based on certain health indicators. Participants will be divided into three groups: one group will receive usual care, another will get support through a digital program, and the third will have both digital and in-person support. The goal is to help participants improve their diet, increase physical activity, lose weight, and better manage their blood sugar levels.

To be eligible for this trial, participants need to be between 18 and 70 years old, live in certain Finnish regions, and have a specific score indicating their risk for diabetes. They should also be comfortable using a smartphone or computer with internet access. It’s important to note that individuals currently living with diabetes, pregnant or breastfeeding women, and those with certain recent health conditions, like cancer, cannot participate. By taking part in this study, individuals will not only receive guidance on improving their health but will also contribute to important research aimed at preventing type 2 diabetes in the community.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • age of 18-70 years
• • 12 points or more in the Finnish diabetes risk score or previous gestational diabetes or repeated impaired fasting glucose (IFG) (fasting plasma glucose level 6,1 - 6,9 mmol/l) or impaired glucose tolerance (2-hour glucose level 7,8 - 11,0 mmol/l in oral glucose tolerance test)
• • living in the hospital district of Northern Savo, Päijät-Häme or South Karelia
• • possibility to use computer, smartphone or tablet with internet connection
• • having own self-phone number
• • adequate Finnish language skill
• Exclusion Criteria:
• • type 1 or 2 diabetes
• • pregnancy or breastfeeding
• • current cancer or less than 6 months from the end of cancer treatment